Lung Adenocarcinoma with Pulmonary Miliary Metastases and Complex Somatic Heterozygous EGFR Mutation

The pretreatment detection of an activating mutation of EGFR is now routinely performed in metastatic nonsquamous non-small cell lung cancer (NSCLC). The therapeutic impact of such a detection is major, as patients with advanced NSCLC exhibiting a mutation of exon 19 or 21 will benefit from EGFR-tyr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Alexandre Schaller, Michèle Beau-Faller, Bertrand Mennecier, Benjamin Renaud-Picard, Noëlle Weingertner, Gilbert Massard, Elisabeth Quoix
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Karger Publishers 2014-11-01
coleção:	Case Reports in Oncology
Assuntos:	EGFR mutations Lung miliary metastases EGFR-tyrosine kinase inhibitor primary resistance Non-small cell lung cancer Lung adenocarcinoma
Acesso em linha:	http://www.karger.com/Article/FullText/369526
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!